Delivery Order SPE2DB20D2014-SPE2DB25FB17H
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,976.80 firm fixed-price delivery order is for the supply of the drug febuxostat 80 mg tablets. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,562,906 units of Febuxostat 40 mg tablets. The firm-fixed-price delivery order contract, valued at $1,061.78, has a completion date of November 28, 2023. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,253.01 Firm Fixed Price Delivery Order contract is for the supply of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,290.59, is a Firm Fixed Price Delivery Order for the provision of Febuxostat 40 mg tablets. The award has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,280.57 fixed-price contract is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a range of...
This federal contract award, valued at $4,147.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of febuxostat 40 mg tablets, a medication used to treat gout. The contract is a firm fixed-price delivery order with a completion date of March 5, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Febuxostat 40 mg tablets, a medication used to treat gout, to the Defense Logistics Agency (DLA). The $7,353.01 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 13, 2024, with a period of performance through November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,611.32 Firm Fixed Price delivery order is for the delivery of 4562163921 - Febuxostat 80 mg Tablets, 30s. The contract has an ultimate completion date of September 14, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,307.73, is a Firm Fixed Price Delivery Order for the supply of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,688.31 Firm Fixed Price Delivery Order is for the supply of Febuxostat 40 mg Tablets, a medication used to treat gout. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...